TE Tirzepatide Editorial

Research

Dr. Parmis Mojarab

Released: · Last reviewed:

Direct answer

Dr. Parmis Mojarab, shown in bylines as “Dr. Parmis”, is a Medical Researcher affiliated with Western University of Health Sciences. She researches and drafts pages for Tirzepatide Editorial. Medical review is separate: every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). No clinical-review authority is asserted for this role.

Key takeaways

  • Dr. Parmis Mojarab (“Dr. Parmis” in bylines) is a Medical Researcher, Western University of Health Sciences.
  • She researches and drafts pages; she does not perform medical review.
  • Every page she researches is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC).
  • No clinical-review authority is asserted for this role.
Key facts
RoleMedical Researcher
AffiliationWestern University of Health Sciences
BylineDr. Parmis
ScopeResearch and drafting of pages. Not medical review.
Medical review of her pagesDr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC)
Clinical-review authorityNone asserted for this role
Partially verified
Medical reviewers Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Released 2026-07-22
Updated
Methodology v4.1

Role

Dr. Parmis Mojarab is a Medical Researcher affiliated with Western University of Health Sciences, credited in bylines as “Dr. Parmis”. She researches and drafts pages for this site. She is not a medical reviewer: every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC), whose NPI records are verified in the CMS NPPES registry, and no clinical-review authority is asserted for this role.

All reviewers

How much of this site's data is actually verified?

Trials with full identifiers8Trials partially verified1Trials withheld pending audit1Providers with a standing all-in price15Providers listed with a reason28$/month
The published state of every dataset behind this site. Of 43 provider records in the November 8, 2026 index, 15 publish a standing all-in price; the other 28 are listed with the reason (18 print a figure that is not like-for-like, 10 have no comparable price) rather than being quietly estimated.
Data for: Verification state of the published datasets
GroupRecords
Trials with full identifiers8
Trials partially verified1
Trials withheld pending audit1
Providers with a standing all-in price15
Providers listed with a reason28
Evidence statuses applied across every page and dataset
Evidence statusDefinitionWhat may be published
VerifiedChecked against a primary source with a recorded dateThe claim, with its identifier and date
Partially verifiedSome elements confirmed, others outstandingConfirmed elements only; the rest labelled
Verification PendingNot yet checked against a primary sourceNo factual assertion — the gap is shown

What are the limits of what this page can tell you?

Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.

Specific limitations.
  • The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
  • Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
  • Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
  • Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.

What would change the conclusion on this page?

Any of the following would change what this page concludes:

  • New primary evidence bearing directly on dr. parmis mojarab.
  • A change to FDA labelling affecting any statement made above.
  • A verified correction submitted through the corrections process and accepted on the evidence.
  • A material change to a captured record, including a price, term, or regulatory status.
  • Completion of a verification currently marked pending, which would replace a gap with a stated fact.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.
2026-09-04Shared cost components and disclosures rebuilt from the 2026-09-04 dataset (NexLife September 2026 card re-read live; Yucca Health and a program since removed from this site added; NexLife disclosed as a commercial partner, labelled where it appears).
2026-11-08Profile updated: role described as Medical Researcher, Western University of Health Sciences (shown in bylines as “Dr. Parmis”), who researches and drafts pages; replaces the earlier Editorial Auditor (editorial governance) description. Medical review of every page by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) stated; no clinical-review authority asserted. Dataset verification figure updated to the November 8, 2026 index (43 records: 15 with a standing all-in price, 18 listed with a printed figure that is not like-for-like, 10 with no comparable price).

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?